trending Market Intelligence /marketintelligence/en/news-insights/trending/dlforpwwdmda01ikv_4iew2 content esgSubNav
In This List

AIG must defend Cosby; CFIUS signs off on Genworth/China Oceanwide deal

Blog

The Big Picture 2022 Insurance Industry Outlook

Podcast

Next in Tech | Episode 37: Insurance impacts on technology and vice versa

Case Study

A Prestigious Global Business School Gains a Competitive Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage


AIG must defend Cosby; CFIUS signs off on Genworth/China Oceanwide deal

A federal appeals court has ruled that American International Group Inc. must defend famed comedian Bill Cosby against defamation claims made by nine women, Business Insurance reported. The insurer initially agreed to foot the legal bill but backtracked later, citing policy language. After Cosby sued, the 1st U.S. Circuit Court of Appeals in Boston ruled that AIG must defend him based on the broadly worded sexual misconduct exclusion in the umbrella policy.

Shifting to M&A, Genworth Financial Inc., an American insurance company, and China Oceanwide Holdings Group Co. Ltd. received clearance from the Committee on Foreign Investment in the U.S., or CFIUS, as part of their long-pending merger deal.

In Japan, Dai-ichi Life Holdings Inc. is leading the race to acquire Suncorp Group Ltd.'s life insurance operations, The Australian reported. Dai-ichi Life has been conducting due diligence to buy the business from the Australia-based insurer and lender for some time.

Tokio Marine HCC subsidiary HCC International Insurance Co. PLC entered into an agreement with Qdos Holdings Ltd. and other selling shareholders to acquire Qdos Contractor of The Qdos Group.

And, National Bank of Greece SA received a binding offer from Shanghai-based investment group Gongbao for a majority stake in its wholly owned insurance unit Ethniki Hellenic General Insurance Co. SA, Reuters reported.

Featured news

KKR in $9.9B deal for Envision; Sanofi, Lilly no clue on Trump insulin deal: KKR is acquiring U.S. medical services provider Envision Healthcare in a transaction valued at about $9.9 billion; and Sanofi said it has not received any proposal from the White House to lower the list price of insulin for Medicare beneficiaries.

Financial news in other parts of the world

Asia-Pacific: Dai-ichi Life top contender for Suncorp life ops; ICICI Bank faces US scrutiny

Europe: Swiss voters reject banking reform; UK FCA goes ahead with disputed listing rule

Middle East & Africa: Commercial Bank ends United Arab Bank stake sale talks; Moody's downgrades Gabon

The day ahead

Early morning futures indicators pointed to a mixed opening for the U.S. market.

In Asia, the Hang Seng was up 0.34% to 31,063.70. The Nikkei 225 rose 0.48% to 22,804.04. In Europe as of midday, the FTSE 100 was up 0.91% to 7,750.65, and the Euronext 100 rose 0.43% to 1,062.12.

On the macro front

No notable reports are due out today.

The Daily Dose has an editorial deadline of 7:30 a.m. ET. Some external links may require a subscription. Links are current as of publication time, and we are not responsible if those links are unavailable later.